Scope Biosciences
Developing a CRISPR-Cas based diagnostic platform for rapid point of care diagnostic solutions.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
* | N/A | Early VC | |
| Total Funding | 000k | ||
Related Content
Scope Biosciences is a pioneering company in the field of medical technology, based in Wageningen, Netherlands. The company specializes in developing a CRISPR Cas-based diagnostic platform called ScopeDx. This platform is designed to provide rapid, point-of-care diagnostic solutions, meaning it can deliver quick and accurate test results directly at the location where the patient is receiving care.
Scope Biosciences serves a diverse range of clients across multiple industries, including healthcare, food safety, and research laboratories. Their primary market is the healthcare sector, where there is a high demand for fast and reliable diagnostic tools. However, the adaptability of their technology allows them to cater to other sectors that require precise detection of genetic material.
The business model of Scope Biosciences revolves around the commercialization of their ScopeDx platform. They generate revenue by selling diagnostic kits and partnering with other companies to integrate their technology into various applications. For example, they have partnered with GenDx, experts in transplant diagnostics, to enhance their offerings in the healthcare market. Additionally, they provide research kits for laboratories worldwide, enabling scientists to utilize their advanced diagnostic system for various research purposes.
Scope Biosciences has successfully raised funding through various grants and partnerships, including the Atlas Invest Entrepreneurship Grant and collaborations with organizations like Philips and EIT Health. These financial boosts have allowed them to further develop and validate their technology, ensuring it meets the highest standards of accuracy and reliability.
In summary, Scope Biosciences is at the forefront of diagnostic innovation, offering a versatile and highly accurate platform that meets the needs of multiple industries. Their ability to adapt and expand their technology makes them a significant player in the medtech market.
Keywords: CRISPR, diagnostics, healthcare, food safety, research, point-of-care, genetic material, ScopeDx, medtech, innovation.